Ask AI
ProCE Banner Activity

ExpressPoints: Novel Therapies for Relapsed or Refractory HER2-Positive Metastatic Breast Cancer

Slideset
Download this short summary slideset of key takeaway points from a live presentation on the novel therapies for relapsed or refractory HER2-postivie metastatic breast cancer.

Released: May 29, 2020

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Thomas Bachelot, MD, PhD

Chair, Unicancer National Breast Cancer Group – UCBG
Department of Medical Oncology
Léon Bérard Center
Lyon, France

Adam M. Brufsky, MD, PhD

Associate Professor
Department of Medicine, Division of Hematology/Oncology
University of Pittsburgh
Pittsburgh, Pennsylvania

Cristina Saura Manich, MD, PhD

Head, Breast Cancer Unit
Medical Oncology Service
Vall d’Hebron University Hospital
Breast Cancer Program, Vall d’Hebron Institute of Oncology (VHIO)
Barcelona, Spain